oral semaglutide nejm in Early Type 1 Diabetes My first paper in NEJM

adults, more than half of the adult population, would qualify for the anti-obesity drug semagludtide

Over the last few years, however, Ozempic has become widely used off-label by non-diabetics seeking dramatic weight loss results, thanks in large part to social media hype, celebrity endorsements, and misperceptions about its long-term safety

Amy Freeman, MD, is a New Jersey-based dermatologist with Millburn Laser Center and a member of the American Academy of Dermatology

This is what causes diabetic eye disease, a leading cause of vision loss

Schedule a consultation with our team to determine whether a medically supervised weight management program is right for you